First-line treatment strategies for newly diagnosed chronic myeloid leukemia: a network meta-analysis

OBJECTIVES: With bosutinib proven to be available for frontline treatment, there are currently four frontline treatments as well as an additional strategy with high-dose imatinib for newly diagnosed chronic myeloid leukemia (CML). Due to the lack of direct comparison of high-dose imatinib, dasatinib...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kang-Kang, Du, Tai-Feng, Wu, Ku-Sheng, Yang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163008/
https://www.ncbi.nlm.nih.gov/pubmed/30288121
http://dx.doi.org/10.2147/CMAR.S177566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163008/
https://www.ncbi.nlm.nih.gov/pubmed/30288121
http://dx.doi.org/10.2147/CMAR.S177566

Ejemplares similares